pieris.com

Pieris Pharmaceuticals, Inc. (PIRS)

Anemia and Other Disease Areas. Slide" data-cycle-swipe="true" data-cycle-timeout=0 data-cycle-log=false data-cycle-auto-height=container data-cycle-pager=".cycle-pager". Novel Solutions in Oncology and Respiratory. In 2017, Pieris forged strategic alliances with Servier and AstraZeneca to accelerate its transformation into a fully-integrated, biologics R&D and commercial organization, focused on two immunology-related therapeutic areas: immuno-oncology. Learn More ». Pieris in Respiratory Diseases.

http://www.pieris.com/

OVERVIEW OF pieris.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

11

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR PIERIS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

August

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 2.8 out of 5 with 5 reviews

5 star

0

4 star

1

3 star

3

2 star

0

1 star

1

Hey there! Start your review of pieris.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1 seconds

FAVICON PREVIEW

16x16
32x32

CONTACTS AT PIERIS.COM

Pieris AG

Rita Fischer

Lise-Mei●●●●●●●●rasse 30

Freisin●●●●●●●stephan , 85354

DE

49.81●●●●●11400

49.81●●●●●11444

in●●@pieris-ag.com

View this contact

Pieris AG

Rita Fischer

Lise-Mei●●●●●●●●rasse 30

Freisin●●●●●●●stephan , 85354

DE

49.81●●●●●11400

49.81●●●●●11444

in●●@pieris-ag.com

View this contact

AMAN Media GmbH

AMAN Media GmbH

Dorfst●●●●●● 2 - 4

Unte●●●●bach , 85235

DE

49.8●●●●9100

49.8●●●●9110

ad●●●@aman.de

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 1999 May 25
UPDATED: 2014 March 13
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

26

YEARS
1

MONTHS
4

DAYS

NAME SERVERS

1: ns3.aman-media.de
2: ns4.aman-media.de

REGISTRAR

1 API GMBH

WHOIS : whois.1api.net

REFERRED : http://www.1api.net

CONTENT

PAGES IN
THIS WEBSITE

11

SSL

EXTERNAL LINKS

11

SITE IP

50.17.179.180

LOAD TIME

0.953 sec

SCORE

6.2

PAGE TITLE

Pieris Pharmaceuticals, Inc. (PIRS) | pieris.com Reviews

<META> DESCRIPTION

Anemia and Other Disease Areas. Slide data-cycle-swipe=true data-cycle-timeout=0 data-cycle-log=false data-cycle-auto-height=container data-cycle-pager=.cycle-pager. Novel Solutions in Oncology and Respiratory. In 2017, Pieris forged strategic alliances with Servier and AstraZeneca to accelerate its transformation into a fully-integrated, biologics R&D and commercial organization, focused on two immunology-related therapeutic areas: immuno-oncology. Learn More ». Pieris in Respiratory Diseases.

<META> KEYWORDS

1 overview

2 history

3 corporate strategy

4 management team

5 board of directors

6 anticalin technology

7 advantages

8 libraries

9 intellectual property

10 publications

CONTENT

Page content here

KEYWORDS ON PAGE

overview,history,corporate strategy,management team,board of directors,anticalin technology,advantages,libraries,intellectual property,publications,pipeline,immuno oncology,respiratory,partnering,partnering strategy,partners,partnering contact,media,quote

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Pieris Pharmaceuticals, Inc. (PIRS) | pieris.com Reviews

https://pieris.com

Anemia and Other Disease Areas. Slide" data-cycle-swipe="true" data-cycle-timeout=0 data-cycle-log=false data-cycle-auto-height=container data-cycle-pager=".cycle-pager". Novel Solutions in Oncology and Respiratory. In 2017, Pieris forged strategic alliances with Servier and AstraZeneca to accelerate its transformation into a fully-integrated, biologics R&D and commercial organization, focused on two immunology-related therapeutic areas: immuno-oncology. Learn More ». Pieris in Respiratory Diseases.

SUBDOMAINS

ir.pieris.com

Overview :: Pieris Pharmaceuticals, Inc. (PIRS)

Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin. Technology to create differentiated drugs that may help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need. Pieris has a diverse pipeline of Anticalin Therapeutics for a number of different indications and has active, multi-program R&D collaborations with Daiichi Sankyo, the Sanofi Group, Zydus Cadila and Stelis Biopharma. Pieris Pharma...

INTERNAL PAGES

pieris.com

1

Press Releases :: Pieris Pharmaceuticals, Inc. (PIRS)

https://www.pieris.com/news-and-events/press-releases

Aug 10, 2016. Pieris Pharmaceuticals Reports Financial Results and Provides Corporate Update for the Second Quarter Ended June 30, 2016. Aug 1, 2016. Pieris Pharmaceuticals to Host Second Quarter 2016 Investor Call and Corporate Update on August 11, 2016. Jul 26, 2016. Pieris Pharmaceuticals Appoints Julian Adams, Ph.D., to Its Board of Directors. Jun 14, 2016. Pieris Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences. Jun 8, 2016. Jun 3, 2016. May 11, 2016. Apr 27, 2016.

2

Overview :: Pieris Pharmaceuticals, Inc. (PIRS)

https://www.pieris.com/pipeline/overview

Pieris has established a proprietary portfolio of unique product opportunities in anemia, asthma and oncology. Based on the promise of our unique therapeutic approach in immuno-oncology, we intend to make this a core franchise of the Company. Phase 2 in progress. Pre-Clinical Phase in progress. Phase 1 not started. Phase 2 not started. PRS-343 is a bivalent, bispecific fusion protein targeting CD137 (4-1BB) and HER2 comprising an agonistic CD137-targeting Anticalin genetically linked to a HER2-targeting ...

3

Partnering Strategy :: Pieris Pharmaceuticals, Inc. (PIRS)

https://www.pieris.com/partnering

Nearly ten Anticalin-based therapeutic programs are currently being advanced under partnership collaborations. Armed with positive human data and not broadly partnered, the Anticalin technology is one of the most mature next generation therapeutic protein technologies available for partnering today. Pieris is always happy to discuss partnering opportunities in the following areas:. Fully proprietary Anticalin drug candidates, where Pieris funds all development costs. PRS-080 (hepcidin antagonist to t...

4

Partnering Strategy :: Pieris Pharmaceuticals, Inc. (PIRS)

https://www.pieris.com/partnering/partnering-strategy

Nearly ten Anticalin-based therapeutic programs are currently being advanced under partnership collaborations. Armed with positive human data and not broadly partnered, the Anticalin technology is one of the most mature next generation therapeutic protein technologies available for partnering today. Pieris is always happy to discuss partnering opportunities in the following areas:. Fully proprietary Anticalin drug candidates, where Pieris funds all development costs. PRS-080 (hepcidin antagonist to t...

5

Upcoming Events :: Pieris Pharmaceuticals, Inc. (PIRS)

https://www.pieris.com/news-and-events/upcoming-events

Business and Investor Conferences. September 3 - September 7, 2016. European Respiratory Society International Congress. September 11 - September 13, 2016. Rodman and Renshaw 18th Annual Healthcare Conference. New York, NY. September 25 - September 28, 2016. CRI-CIMT-EATI-AACR - The Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival. New York, NY. September 28 - September 30, 2016. World Bispecific Antibody Summit. October 31 - November 4, 2016. New York, NY. Fully...

UPGRADE TO PREMIUM TO VIEW 6 MORE

TOTAL PAGES IN THIS WEBSITE

11

LINKS TO THIS WEBSITE

ir.pieris.com

Press Releases :: Pieris Pharmaceuticals, Inc. (PIRS)

http://ir.pieris.com/press-releases/detail/506/pieris-pharmaceuticals-to-host-second-quarter-2015-investor

Pieris Pharmaceuticals to Host Second Quarter 2015 Investor Call on August 13th. FREISING, GERMANY - (Marketwired) - 07/30/15 -. Pieris Pharmaceuticals, Inc. A biotechnology company advancing its proprietary Anticalin. Biotherapeutic technologies, announced today that it will conduct a conference call on Thursday, August 13 at 10:00 AM (EDT) to discuss second quarter 2015 business and financial results. Pieris is a clinical-stage biotechnology company advancing its proprietary Anticalin. Source: Pieris P...

bio-m.org

BioM AG - bio-m.org

http://www.bio-m.org/biom-ag.html

Netzwerk - Ihr Cluster. AG Munich Biotech Development ist ein Beratungs- und Beteiligungsunternehmen mit Sitz in Martinsried im Zentrum der BioTech-Region München. Die Bio. AG unterstützt mit ihrem Seed-Finanzierungsprogramm junge und viel versprechende Biotechnologieunternehmen, insbesondere in der Gründungs- und der Start-up-Phase mit einem Schwerpunkt auf die medizinische Biotechnologie. Die Investments erfolgen aus dem Eigenkaptal der Bio. AG heraus. Die Bio. Zudem steht die Bio. AG über ein umfangre...

intuitivevp.com

IVP Investments

http://www.intuitivevp.com/investments.html

M2M Spectrum Networks is the first company to provide comprehensive solutions for creating, connecting and managing machine-to-machine (M2M) communications for The Internet. PeerNova has developed the first immutable ledger with built-in audit, control, scale, and other capabilities necessary to help the world’s most trusted organizations store, secure, and validate their data. ViewRay, Inc. (OTCQB: VRAY). Http:/ www.viewray.com. Pieris Pharmaceuticals, Inc. Http:/ www.pieris.com/. CÜR is a new streaming...

eurocalin.consultech.de

Pieris GmbH | The EUROCALIN Project

http://www.eurocalin.consultech.de/project/partner/pieris/page9.html

Med Univ. of Innsbruck. Techn Univ. München. Pieris is the project coordinator of the Consortium, responsible for scientific management. The company, in addition to providing PRS-080 candidate molecule, contributes key intellectual property for the Anticalin technology, characterization and optimization of the PRS-080 molecule, assay development, CMC formulation and development experience. Pieris Pharmaceuticals GmbH, ( www.pieris.com. For media inquiries, please contact media "at" pieris-ag.com.

digital-pillbox.com

pboyerbarresi | The Digit@l Pillbox - Life Sciences Industry Trends

https://digital-pillbox.com/author/pboyerbarresi

The Digit@l Pillbox – Life Sciences Industry Trends. On-Demand Dose of Relevant Life Sciences Successes and Challenges. About Pascale Boyer Barresi. Health Systems and Market Access. Good Pieces of Advice. How to Be an Expert in a Changing World – Paul Graham. Love the Problem, Not Your Solution – Ash Maurya. Digital Health – Healthy Me. Infectious Diseases – Bugs & Drugs. My Stroke of Insight – A Brain Scientist’s Personal Journey. Top 15 Pharma companies – FY 2016 performance review. February 10, 2017.

ir.pieris.com

Press Releases :: Pieris Pharmaceuticals, Inc. (PIRS)

http://ir.pieris.com/press-releases/detail/507/pieris-pharmaceuticals-reports-financial-results-for-the

Pieris Pharmaceuticals Reports Financial Results for the Second Quarter Ended June 30, 2015. Company to Host an Investor Conference Call on Thursday, August 13, 2015 at 10:00 AM EDT. FREISING, GERMANY - (Marketwired) - 08/12/15 -. Pieris Pharmaceuticals, Inc. A biotechnology company advancing its proprietary Anticalin. Biotherapeutic technologies, today reported financial results for the second quarter of 2015, and provided an update on the Company's recent developments. Uplisted to the NASDAQ. The Compa...

UPGRADE TO PREMIUM TO VIEW 5 MORE

TOTAL LINKS TO THIS WEBSITE

11

OTHER SITES

pieris-immobilier.com

PIERIS PATRIMOINE IMMOBILIER

La gestion de patrimoine. Conseils en valorisation de patrimoine. Conseils en gestion de patrimoine. Médiation entre proprietaires et locataires. Conseil juridique en immobilier. 92 - Hauts de Seine. 94 - Val de Marne. AVEC L'IMMOBILIER, CONSTRUISONS ENSEMBLE. DES A PRESENT VOTRE FUTUR. Vendre votre bien immobilier. À Paris ou en région parisienne. Acheter un bien comme résidence principale ou investissement locatif. Obtenir une estimation de votre bien immobilier au juste prix du marché. Que vous souhai...

pieris-portal.blogspot.com

Pieris · Πιερίς

Pieris · Πιερίς. Interaktív művészeti portál - hivatalos bolg. A múzsák a görög mitológiában a mítoszok megtestesítői, a költészet, a zene, a tánc és a tudományok istennői, az emlékezés és az improvizáció ihletői. A múzsák első lakhelye az Olümposz alatti síkság, Pieria. 2015 május 7., csütörtök. Pieris.hu - Programajánló, kulturális eseménynaptár. Ebben a rovatban különböző kulturális programok ajánlóit olvashatjátok, melyek többségükben magyarországi programok. A témaköröket tekintve mozi ajánló. Úgy g...

pieris-rousseau.com

Pierre Rousseau

Promontorium somnii les choses de l'infini. Victor Hugo Proses Philosophiques.

pieris.ch

www.pieris.ch - Schmetterlinge der Schweiz - Butterflies & Moths of Switzerland

Schmetterlinge der Schweiz - Butterflies and Moths of Switzerland. Fotos - Verbreitung - Biologie. 1870 Seiten (Arten, Unterarten). Bilder aus der Schweiz. 28364 Bilder aus der Schweiz. Fundorte der Schweiz (SHIFT-G). Falter unter dem Mikroskop (SHIFT-M). Die neuesten Bilder (SHIFT-N). Zuletzt bearbeitete Seiten (SHIFT-Y). Züchten und Fotografieren (SHIFT-Z). Heiner Ziegler, Chur: 2005-2016.

pieris.com

Pieris Pharmaceuticals, Inc. (PIRS)

Anemia and Other Disease Areas. Slide" data-cycle-swipe="true" data-cycle-timeout=0 data-cycle-log=false data-cycle-auto-height=container data-cycle-pager=".cycle-pager". Novel Solutions in Oncology and Respiratory. In 2017, Pieris forged strategic alliances with Servier and AstraZeneca to accelerate its transformation into a fully-integrated, biologics R&D and commercial organization, focused on two immunology-related therapeutic areas: immuno-oncology. Learn More ». Pieris in Respiratory Diseases.

pieris.com.au

Pieris - Building, Painting and Commercial Cleaning

07 5536 1052 Email. Pieris Pty Ltd is the leader when it comes to protecting the investment in your building. We specialise in Building. And have been trusted by customers on the Coast for over 20 years. Please take some time to learn more.

pieris.cz

Pieris.cz, originální samolepky a dekorace

Poštovné od 49 Kč. U objednávek nad 1500 Kč ZDARMA. Možný osobní odběr v prodejně v Hradci Králové. Nažehlovací obrázky na textil. Pomůcky pro lepení samolepek. NOVINKY v naší nabídce. Silnice - samolepící bordura na zeď. Ceny poštovného a dopravy. Možnost osobního odběru v Hradci Králové. Návody a informace k samolepkám. Samolepky na míru a 3D návrh interiéru. Originální české sklo vyráběné technologií Fussing. Samolepky na zeď pro děti i dospělé, samolepky na zakázku, české dekorační sklo. Doporučujeme...

pieris.de

STRATO

pieris.eu

Pieris.eu | Information about Pieris japonica and Kalmia Latifolia

Pieris and Kalmia Nursery. Welcome to Pieris.eu! Is the website of nursery G. van Santvoort. G van Santvoort is specialized in cultivating Pieris japonica since 1980. With almost 30 years of experience nursery G. van Santvoort has become a Pieris japonica specialist. In 1996 we even discovered a new Pieris japonica variety: Pieris japonica 'Carnaval'. Nursery G. van Santvoort. Posted on February 6, 2008 by Admin. Nursery G. van Santvoort. Posted on February 6, 2008 by Admin. Pieris and Kalmia News.

pieris.hu

Pieris • Vers, Versek, Irodalom, Költészet, Zene • Írók, Költők, Poéták, Zenészek

Interaktív kortárs művészeti portál. A múzsák a görög mitológiában a mítoszok megtestesítői, a költészet, a zene, a tánc és a tudományok istennői, az emlékezés és az improvizáció ihletői. A múzsák első lakhelye az Olümposz alatti síkság, Pieria. Hasznos tudnivalók, cikkek. Külön vagy egybe írjuk? A1 - 1008 X 80px. Köszöntünk a Pieris.hu interaktív kortárs művészeti portálon. Szeretettel köszöntünk a Pieris.hu interaktív kortárs. Nagy érdeklődéssel várunk minden irodalmi ( vers. Portálunkra, és töltsd fel...